Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Webb

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|March 4, 2023
A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studiesChristopher M Conner, Don van Fossan, Kristen Read, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2011
Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient populationJames O Burton, Laura J Gray, David R Webb, et al.
Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.
Journal of Diabetes|September 8, 2018
Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide studyNafeesa N Dhalwani, Francesco Zaccardi, Hina Waheed, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 1, 2023
The effects of weight-lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta-analysis of randomized controlled trialsRishi Jobanputra, Jack A Sargeant, Abdullah Almaqhawi, et al.
Diabetologia|June 3, 2020
Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trialsJack A Sargeant, Emer M Brady, Francesco Zaccardi, et al.
Protein Science : a Publication of the Protein Society|January 14, 2004
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formationKathleen Aertgeerts, Sheng Ye, Mike G Tennant, et al.
Diabetologia|March 19, 2017
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validationFrancesco Zaccardi, David R Webb, Melanie J Davies, et al.
Protein Science : a Publication of the Protein Society|December 24, 2003
N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase bindingKathleen Aertgeerts, Sheng Ye, Lihong Shi, et al.
Blood|May 7, 2009
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPasesYibing Xu, Jianwu Li, Gregory D Ferguson, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|March 4, 2023
A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studiesChristopher M Conner, Don van Fossan, Kristen Read, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2011
Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient populationJames O Burton, Laura J Gray, David R Webb, et al.
Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.
Journal of Diabetes|September 8, 2018
Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide studyNafeesa N Dhalwani, Francesco Zaccardi, Hina Waheed, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 1, 2023
The effects of weight-lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta-analysis of randomized controlled trialsRishi Jobanputra, Jack A Sargeant, Abdullah Almaqhawi, et al.
Diabetologia|June 3, 2020
Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trialsJack A Sargeant, Emer M Brady, Francesco Zaccardi, et al.
Protein Science : a Publication of the Protein Society|January 14, 2004
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formationKathleen Aertgeerts, Sheng Ye, Mike G Tennant, et al.
Diabetologia|March 19, 2017
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validationFrancesco Zaccardi, David R Webb, Melanie J Davies, et al.
Protein Science : a Publication of the Protein Society|December 24, 2003
N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase bindingKathleen Aertgeerts, Sheng Ye, Lihong Shi, et al.
Blood|May 7, 2009
Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPasesYibing Xu, Jianwu Li, Gregory D Ferguson, et al.
Pageof 10